{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:13:40Z","timestamp":1789456420732,"version":"build-2803163510"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00228-026-04141-4","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T03:57:15Z","timestamp":1787284635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Electrocardiographic identification of drug effects: QT prolongation, arrhythmias, and clinical monitoring"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3427-5649","authenticated-orcid":false,"given":"Canan","family":"Akman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0053-5657","authenticated-orcid":false,"given":"Asli Bahar","family":"Ucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6150-2023","authenticated-orcid":false,"given":"Mehmet Can","family":"Girgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4933-3960","authenticated-orcid":false,"given":"Busra","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7621-553X","authenticated-orcid":false,"given":"Gokhan","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7321-5131","authenticated-orcid":false,"given":"Resad","family":"Beyoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8814-6164","authenticated-orcid":false,"given":"Ozgur","family":"Karcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"4141_CR1","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1161\/CIR.0000000000000905","volume":"142","author":"JE Tisdale","year":"2020","unstructured":"Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Leclerc J, Rajagopalan B (2020) Drug-induced arrhythmias: a scientific statement from the American Heart Association. Circulation 142:e214\u2013e233. https:\/\/doi.org\/10.1161\/CIR.0000000000000905","journal-title":"Circulation"},{"key":"4141_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0003-3928(66)80001-6","volume":"59","author":"F Dessertenne","year":"1966","unstructured":"Dessertenne F (1966) La tachycardie ventriculaire \u00e0 deux foyers oppos\u00e9s variables. Arch Mal Coeur Vaiss 59:263\u2013272. https:\/\/doi.org\/10.1016\/S0003-3928(66)80001-6","journal-title":"Arch Mal Coeur Vaiss"},{"key":"4141_CR3","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1056\/NEJMra032426","volume":"350","author":"DM Roden","year":"2008","unstructured":"Roden DM (2008) Drug-induced prolongation of the QT interval. N Engl J Med 350:1013\u20131022. https:\/\/doi.org\/10.1056\/NEJMra032426","journal-title":"N Engl J Med"},{"key":"4141_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrd1092","volume":"2","author":"B Fermini","year":"2003","unstructured":"Fermini B, Fossa AA (2003) The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov 2:439\u2013447. https:\/\/doi.org\/10.1038\/nrd1092","journal-title":"Nat Rev Drug Discov"},{"key":"4141_CR5","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.4103\/jfmpc.jfmpc_1060_20","volume":"9","author":"B Das","year":"2020","unstructured":"Das B, Ramasubbu SK, Agnihotri A, Kumar B, Rawat VS (2020) Top 20 drug\u2013drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients. J Family Med Prim Care 9:6023\u20136040. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1060_20","journal-title":"J Family Med Prim Care"},{"key":"4141_CR6","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jacc.2010.01.001","volume":"55","author":"BJ Drew","year":"2010","unstructured":"Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V et al (2010) Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 55:934\u2013947. https:\/\/doi.org\/10.1016\/j.jacc.2010.01.001","journal-title":"J Am Coll Cardiol"},{"key":"4141_CR7","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1111\/bcp.15383","volume":"88","author":"E Vandael","year":"2022","unstructured":"Vandael E, Vandenberk B, Vandenberghe J, Willems R, Foulon V (2022) Use of electrocardiogram monitoring in adult patients taking high-risk QT interval prolonging medicines in clinical practice: systematic review and meta-analysis. Br J Clin Pharmacol 88:4448\u20134461. https:\/\/doi.org\/10.1111\/bcp.15383","journal-title":"Br J Clin Pharmacol"},{"key":"4141_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/415198a","volume":"415","author":"DM Bers","year":"2002","unstructured":"Bers DM (2002) Cardiac excitation-contraction coupling. Nature 415:198\u2013205. https:\/\/doi.org\/10.1038\/415198a","journal-title":"Nature"},{"key":"4141_CR9","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1161\/CIRCULATIONAHA.118.035948","volume":"138","author":"JR Giudicessi","year":"2018","unstructured":"Giudicessi JR, Noseworthy PA, Ackerman MJ (2018) The QT interval. Circulation 138:e197\u2013e200. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035948","journal-title":"Circulation"},{"key":"4141_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/01.RES.0000016960.61087.86","volume":"90","author":"K Gima","year":"2002","unstructured":"Gima K, Rudy Y (2002) Ionic current basis of electrocardiographic waveforms: a model study. Circ Res 90:889\u2013896. https:\/\/doi.org\/10.1161\/01.RES.0000016960.61087.86","journal-title":"Circ Res"},{"key":"4141_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0092-8674(01)00243-4","volume":"104","author":"MT Keating","year":"2001","unstructured":"Keating MT, Sanguinetti MC (2001) Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104:569\u2013580. https:\/\/doi.org\/10.1016\/S0092-8674(01)00243-4","journal-title":"Cell"},{"key":"4141_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.pharmthera.2008.05.009","volume":"119","author":"JC Hancox","year":"2008","unstructured":"Hancox JC, McPate MJ, El Harchi A, Zhang YH (2008) The hERG potassium channel and hERG screening for drug-induced torsades de pointes. Pharmacol Ther 119:118\u2013132. https:\/\/doi.org\/10.1016\/j.pharmthera.2008.05.009","journal-title":"Pharmacol Ther"},{"key":"4141_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrcardio.2015.110","volume":"13","author":"G Frommeyer","year":"2016","unstructured":"Frommeyer G, Eckardt L (2016) Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms. Nat Rev Cardiol 13:36\u201347. https:\/\/doi.org\/10.1038\/nrcardio.2015.110","journal-title":"Nat Rev Cardiol"},{"key":"4141_CR14","doi-asserted-by":"publisher","first-page":"H525","DOI":"10.1152\/ajpheart.00904.2002","volume":"285","author":"P Smetana","year":"2003","unstructured":"Smetana P, Batchvarov V, Hnatkova K, Camm AJ, Malik M (2003) Ventricular gradient and nondipolar repolarization components increase at higher heart rates. Am J Physiol Heart Circ Physiol 285:H525\u2013H532. https:\/\/doi.org\/10.1152\/ajpheart.00904.2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4141_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jacc.2009.10.033","volume":"55","author":"G Antoons","year":"2010","unstructured":"Antoons G, Oros A, Beekman JD, Engelen MA, Houtman MJ, Belardinelli L et al (2010) Late Na+ current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model. J Am Coll Cardiol 55:801\u2013809. https:\/\/doi.org\/10.1016\/j.jacc.2009.10.033","journal-title":"J Am Coll Cardiol"},{"key":"4141_CR16","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jelectrocard.2017.08.003","volume":"50","author":"J Vicente","year":"2017","unstructured":"Vicente J, Hosseini M, Johannesen L, Strauss DG (2017) Electrocardiographic biomarkers to confirm drug\u2019s electrophysiological effects used for proarrhythmic risk prediction under CiPA. J Electrocardiol 50:808\u2013813. https:\/\/doi.org\/10.1016\/j.jelectrocard.2017.08.003","journal-title":"J Electrocardiol"},{"key":"4141_CR17","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1136\/heartjnl-2017-311761","volume":"103","author":"PE Lazzerini","year":"2017","unstructured":"Lazzerini PE, Laghi-Pasini F, Bertolozzi I, Morozzi G, Lorenzini S, Simpatico A et al (2017) Systemic inflammation as a novel QT-prolonging risk factor in patients with the congenital long QT syndrome. Heart 103:1821\u20131829. https:\/\/doi.org\/10.1136\/heartjnl-2017-311761","journal-title":"Heart"},{"key":"4141_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00424-010-0840-y","volume":"460","author":"A Varr\u00f3","year":"2011","unstructured":"Varr\u00f3 A, Baczko I (2011) Possible mechanisms of sudden cardiac death in top athletes: a basic cardiac electrophysiological point of view. Pflugers Arch 460:31\u201340. https:\/\/doi.org\/10.1007\/s00424-010-0840-y","journal-title":"Pflugers Arch"},{"key":"4141_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1046\/j.1540-8167.2004.03534.x","volume":"15","author":"RR Fenichel","year":"2004","unstructured":"Fenichel RR, Malik M, Antzelevitch C, Sanguinetti M, Roden DM, Priori SG et al (2004) Drug-induced torsades de pointes and implications for drug development. J Cardiovasc Electrophysiol 15:475\u2013495. https:\/\/doi.org\/10.1046\/j.1540-8167.2004.03534.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"4141_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10557-018-6811-9","volume":"32","author":"H Vyas","year":"2018","unstructured":"Vyas H, Krishnamurthy V, Haqqani HM, Bhaskaran A, Lau DH, Sanders P et al (2018) Drug-induced QT prolongation: mechanisms, clinical importance and management. Cardiovasc Drugs Ther 32:337\u2013350. https:\/\/doi.org\/10.1007\/s10557-018-6811-9","journal-title":"Cardiovasc Drugs Ther"},{"key":"4141_CR21","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/europace\/eus069","volume":"14","author":"EZ Soliman","year":"2012","unstructured":"Soliman EZ, Elsalam MA, Li Y (2012) The relationship between high resting heart rate and ventricular arrhythmogenesis in patients referred to ambulatory 24-h electrocardiographic recording. Europace 14:1215\u20131220. https:\/\/doi.org\/10.1093\/europace\/eus069","journal-title":"Europace"},{"key":"4141_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2174\/1573403X10666140514103612","volume":"10","author":"PG Postema","year":"2014","unstructured":"Postema PG, Wilde AA (2014) The measurement of the QT interval. Curr Cardiol Rev 10:287\u2013294. https:\/\/doi.org\/10.2174\/1573403X10666140514103612","journal-title":"Curr Cardiol Rev"},{"key":"4141_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00000542-200602000-00008","volume":"104","author":"B Charbit","year":"2006","unstructured":"Charbit B, Samain E, Merckx P, Funck-Brentano C (2006) QT interval measurement: reliability of automatic QTc measurement and new simple method to calculate and interpret corrected QT interval. Anesthesiology 104:255\u2013260. https:\/\/doi.org\/10.1097\/00000542-200602000-00008","journal-title":"Anesthesiology"},{"key":"4141_CR24","doi-asserted-by":"publisher","first-page":"e12461","DOI":"10.1111\/anec.12461","volume":"22","author":"T Robyns","year":"2017","unstructured":"Robyns T, Lu HR, Gallacher DJ, Garweg C, Ector J, Willems R et al (2017) Evaluation of heart rate correction methods for QT interval in a normal sinus rhythm and in atrial fibrillation. Ann Noninvasive Electrocardiol 22:e12461. https:\/\/doi.org\/10.1111\/anec.12461","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"4141_CR25","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/j.1540-8159.2008.01219.x","volume":"31","author":"M Malik","year":"2008","unstructured":"Malik M, Hnatkova K, Batchvarov VN (2008) Differences between study-specific and subject-specific heart rate corrections of the QT interval in investigations of drug induced QTc changes. Pacing Clin Electrophysiol 31:1481\u20131490. https:\/\/doi.org\/10.1111\/j.1540-8159.2008.01219.x","journal-title":"Pacing Clin Electrophysiol"},{"key":"4141_CR26","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/0002-9149(92)90562-D","volume":"70","author":"A Sagie","year":"1992","unstructured":"Sagie A, Larson MG, Goldberg RJ, Bengtson JR, Levy D (1992) An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol 70:797\u2013801. https:\/\/doi.org\/10.1016\/0002-9149(92)90562-D","journal-title":"Am J Cardiol"},{"key":"4141_CR27","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.hrthm.2006.04.026","volume":"3","author":"JH Indik","year":"2006","unstructured":"Indik JH, Pearson AC, Fried K, Woosley RL (2006) Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval. Heart Rhythm 3:1003\u20131007. https:\/\/doi.org\/10.1016\/j.hrthm.2006.04.026","journal-title":"Heart Rhythm"},{"key":"4141_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ijcard.2014.04.133","volume":"174","author":"PM Rautaharju","year":"2014","unstructured":"Rautaharju PM, Mason JW, Akiyama T (2014) New age- and sex-specific criteria for QT prolongation based on rate correction formulas that minimize bias at the upper normal limits. Int J Cardiol 174:535\u2013540. https:\/\/doi.org\/10.1016\/j.ijcard.2014.04.133","journal-title":"Int J Cardiol"},{"key":"4141_CR29","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1185\/03007995.2013.840568","volume":"29","author":"KE Trinkley","year":"2013","unstructured":"Trinkley KE, Page RL 2nd, Lien H, Yamanouye K, Tisdale JE (2013) QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Curr Med Res Opin 29:1719\u20131726. https:\/\/doi.org\/10.1185\/03007995.2013.840568","journal-title":"Curr Med Res Opin"},{"key":"4141_CR30","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/j.1540-8159.2000.tb07065.x","volume":"23","author":"A Ghuran","year":"2000","unstructured":"Ghuran A, Batchvarov V, Dilaveris P, F\u00e4rbom P, Camm AJ, Malik M (2000) Reflex autonomic modulation of automatically measured repolarization parameters. Pacing Clin Electrophysiol 23:1973\u20131976. https:\/\/doi.org\/10.1111\/j.1540-8159.2000.tb07065.x","journal-title":"Pacing Clin Electrophysiol"},{"key":"4141_CR31","doi-asserted-by":"publisher","first-page":"H2356","DOI":"10.1152\/ajpheart.00860.2001","volume":"282","author":"VN Batchvarov","year":"2002","unstructured":"Batchvarov VN, Ghuran A, Smetana P, Hnatkova K, Harries M, Dilaveris P et al (2002) QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability. Am J Physiol Heart Circ Physiol 282:H2356\u2013H2363. https:\/\/doi.org\/10.1152\/ajpheart.00860.2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4141_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jelectrocard.2015.10.001","volume":"49","author":"GHW Janssen","year":"2015","unstructured":"Janssen GHW, Rijkenberg S, van der Voort PHJ (2015) Validation of continuous QTc measurement in critically ill patients. J Electrocardiol 49:81\u201386. https:\/\/doi.org\/10.1016\/j.jelectrocard.2015.10.001","journal-title":"J Electrocardiol"},{"key":"4141_CR33","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.118.033943","volume":"138","author":"AS Vink","year":"2018","unstructured":"Vink AS, Neumann B, Lieve KVV, Sinner MF, Hofman N, El Kadi S et al (2018) Determination and interpretation of the QT interval. Circulation 138:2345\u20132358. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.033943","journal-title":"Circulation"},{"key":"4141_CR34","doi-asserted-by":"publisher","first-page":"e12393","DOI":"10.1111\/anec.12393","volume":"22","author":"H Bogossian","year":"2017","unstructured":"Bogossian H, Frommeyer G, Ninios I, Pechlivanidou E, Hasan F, Nguyen QS et al (2017) A new experimentally validated formula to calculate the QT interval in the presence of left bundle branch block holds true in the clinical setting. Ann Noninvasive Electrocardiol 22:e12393. https:\/\/doi.org\/10.1111\/anec.12393","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"4141_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/CIRCOUTCOMES.113.000152","volume":"6","author":"JE Tisdale","year":"2013","unstructured":"Tisdale JE, Jaynes HA, Kingery JR, Mourad NA, Trujillo TN, Overholser BR et al (2013) Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes 6:479\u2013487. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.113.000152","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"4141_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3238\/arztebl.2019.0041","volume":"116","author":"K M\u00f6rike","year":"2019","unstructured":"M\u00f6rike K, Schwab M (2019) Drug-induced QT prolongation in clinical practice: patients at risk, ECG monitoring and evidence-based decision-making. Dtsch Arztebl Int 116:41\u201347. https:\/\/doi.org\/10.3238\/arztebl.2019.0041","journal-title":"Dtsch Arztebl Int"},{"key":"4141_CR37","doi-asserted-by":"publisher","first-page":"e67382","DOI":"10.7759\/cureus.67382","volume":"16","author":"MU Khan","year":"2024","unstructured":"Khan MU, Kirmani BT, Iqbal J, Al-Alawi HM, Khalid SA (2024) Long QT syndrome with drugs used in the management of arrhythmias: a systematic review. Cureus 16:e67382. https:\/\/doi.org\/10.7759\/cureus.67382","journal-title":"Cureus"},{"key":"4141_CR38","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","volume":"89","author":"YG Yap","year":"2003","unstructured":"Yap YG, Camm AJ (2003) Drug induced QT prolongation and torsades de pointes. Heart 89:1363\u20131372. https:\/\/doi.org\/10.1136\/heart.89.11.1363","journal-title":"Heart"},{"key":"4141_CR39","doi-asserted-by":"publisher","first-page":"20R","DOI":"10.1016\/s0002-9149(99)00698-0","volume":"84","author":"I Kodama","year":"1999","unstructured":"Kodama I, Kamiya K, Toyama J (1999) Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent. Am J Cardiol 84:20R\u201328R. https:\/\/doi.org\/10.1016\/s0002-9149(99)00698-0","journal-title":"Am J Cardiol"},{"key":"4141_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.hrthm.2005.01.005","volume":"2","author":"C Antzelevitch","year":"2005","unstructured":"Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al (2005) Brugada syndrome: report of the second consensus conference. Heart Rhythm 2:429\u2013440. https:\/\/doi.org\/10.1016\/j.hrthm.2005.01.005","journal-title":"Heart Rhythm"},{"key":"4141_CR41","doi-asserted-by":"publisher","first-page":"16741","DOI":"10.20452\/pamw.16741","volume":"134","author":"GYH Lip","year":"2024","unstructured":"Lip GYH, Mills MT (2024) Antazoline for pharmacologic cardioversion of atrial fibrillation: teaching an old drug new tricks. Pol Arch Intern Med 134:16741. https:\/\/doi.org\/10.20452\/pamw.16741","journal-title":"Pol Arch Intern Med"},{"key":"4141_CR42","doi-asserted-by":"publisher","first-page":"E560","DOI":"10.1503\/cmaj.160355","volume":"189","author":"G Trifir\u00f2","year":"2018","unstructured":"Trifir\u00f2 G, De Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S et al (2018) Use of azithromycin and risk of ventricular arrhythmia. CMAJ 189:E560\u2013E568. https:\/\/doi.org\/10.1503\/cmaj.160355","journal-title":"CMAJ"},{"key":"4141_CR43","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/jac\/dkx049","volume":"72","author":"ED Bizjak","year":"2017","unstructured":"Bizjak ED, Mauro VF (2017) Antimicrobials and QT prolongation. J Antimicrob Chemother 72:1272\u20131279. https:\/\/doi.org\/10.1093\/jac\/dkx049","journal-title":"J Antimicrob Chemother"},{"key":"4141_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijcard.2021.02.025","volume":"333","author":"M Rao","year":"2021","unstructured":"Rao M, Xi J, Liu Z, Wang F, Deng W (2021) Antibiotic drugs rifampicin and rifabutin interfere with detection of QT interval prolongation using standard automated ECG software. Int J Cardiol 333:35\u201340. https:\/\/doi.org\/10.1016\/j.ijcard.2021.02.025","journal-title":"Int J Cardiol"},{"key":"4141_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.21037\/atm.2018.03.17","volume":"6","author":"WS Aronow","year":"2018","unstructured":"Aronow WS, Shamliyan TA (2018) Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders. Ann Transl Med 6:147. https:\/\/doi.org\/10.21037\/atm.2018.03.17","journal-title":"Ann Transl Med"},{"key":"4141_CR46","doi-asserted-by":"publisher","first-page":"204512532110588","DOI":"10.1177\/20451253211058892","volume":"11","author":"B Das","year":"2021","unstructured":"Das B, Ramasubbu SK, Agnihotri A, Kumar B, Rawat VS (2021) Leading 20 drug\u2013drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients. Ther Adv Psychopharmacol 11:20451253211058892. https:\/\/doi.org\/10.1177\/20451253211058892","journal-title":"Ther Adv Psychopharmacol"},{"key":"4141_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2165\/11591530-000000000-00000","volume":"25","author":"J Nielsen","year":"2011","unstructured":"Nielsen J, Graff C, Kanters JK, Toft E, Taylor D, Meyer JM (2011) Assessing QT interval prolongation and its associated risks with antipsychotics. CNS Drugs 25:473\u2013490. https:\/\/doi.org\/10.2165\/11591530-000000000-00000","journal-title":"CNS Drugs"},{"key":"4141_CR48","doi-asserted-by":"publisher","first-page":"110138","DOI":"10.1016\/j.jpsychores.2020.110138","volume":"135","author":"GL Xiong","year":"2020","unstructured":"Xiong GL, Pinkhasov A, Bourgeois JA, Gagliardi JP, McCoy TA, Vo HT et al (2020) QTc monitoring in adults with medical and psychiatric comorbidities: expert consensus from the Association of Medicine and Psychiatry. J Psychosom Res 135:110138. https:\/\/doi.org\/10.1016\/j.jpsychores.2020.110138","journal-title":"J Psychosom Res"},{"key":"4141_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11096-016-0399-z","volume":"39","author":"E Vandael","year":"2017","unstructured":"Vandael E, Vandenberk B, Vandenberghe J, Willems R, Foulon V (2017) Risk factors for QTc-prolongation: systematic review of the evidence. Int J Clin Pharm 39:16\u201325. https:\/\/doi.org\/10.1007\/s11096-016-0399-z","journal-title":"Int J Clin Pharm"},{"key":"4141_CR50","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00228-023-03497-3","volume":"79","author":"H Al-Momani","year":"2023","unstructured":"Al-Momani H, Al-Momani F, Al-Smadi AM, Al-Momani M, Alfayoumi BM, Al-Ryalat SA (2023) Ondansetron-induced QT prolongation among various age groups: a systematic review and meta-analysis. Eur J Clin Pharmacol 79:843\u2013851. https:\/\/doi.org\/10.1007\/s00228-023-03497-3","journal-title":"Eur J Clin Pharmacol"},{"key":"4141_CR51","doi-asserted-by":"publisher","first-page":"e007724","DOI":"10.1161\/JAHA.117.007724","volume":"7","author":"AN Sharma","year":"2018","unstructured":"Sharma AN, Bhatt DL, Bhattacharyya S, Bhattacharyya M, Bhattacharyya R, Deedwania PC et al (2018) Incidence, diagnosis, and management of QT prolongation induced by cancer therapies: a systematic review. J Am Heart Assoc 7:e007724. https:\/\/doi.org\/10.1161\/JAHA.117.007724","journal-title":"J Am Heart Assoc"},{"key":"4141_CR52","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1200\/JCO.19.00922","volume":"37","author":"EL Strevel","year":"2019","unstructured":"Strevel EL, Ing DJ, Siu LL (2019) Trials and tribulations of corrected QT interval monitoring in oncology: rationale for a practice-changing standardized approach. J Clin Oncol 37:3500\u20133508. https:\/\/doi.org\/10.1200\/JCO.19.00922","journal-title":"J Clin Oncol"},{"key":"4141_CR53","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jacc.2006.08.055","volume":"49","author":"D Zeltser","year":"2007","unstructured":"Zeltser D, Justo D, Halkin A, Rosso R, Ish-Shalom M, Hochenberg M et al (2007) Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug. J Am Coll Cardiol 49:367\u2013372. https:\/\/doi.org\/10.1016\/j.jacc.2006.08.055","journal-title":"J Am Coll Cardiol"},{"key":"4141_CR54","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.mayocp.2020.03.024","volume":"95","author":"JR Giudicessi","year":"2020","unstructured":"Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ (2020) Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19). Mayo Clin Proc 95:1213\u20131221. https:\/\/doi.org\/10.1016\/j.mayocp.2020.03.024","journal-title":"Mayo Clin Proc"},{"key":"4141_CR55","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/cea.13500","volume":"49","author":"M Cataldi","year":"2019","unstructured":"Cataldi M, Maurer M, Taglialatela M, Church MK (2019) Cardiac safety of second-generation H1-antihistamines when updosed in chronic spontaneous urticaria. Clin Exp Allergy 49:1615\u20131623. https:\/\/doi.org\/10.1111\/cea.13500","journal-title":"Clin Exp Allergy"},{"key":"4141_CR56","doi-asserted-by":"publisher","first-page":"e22534","DOI":"10.7759\/cureus.22534","volume":"14","author":"JP Hoffman","year":"2022","unstructured":"Hoffman JP, Serdiuk AA, Escher AR, Bordoni B, Evans R (2022) Diphenhydramine-induced torsade de pointes with pharmacological cardioversion in a patient with methadone-induced QT prolongation. Cureus 14:e22534. https:\/\/doi.org\/10.7759\/cureus.22534","journal-title":"Cureus"},{"key":"4141_CR57","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.jacc.2011.01.040","volume":"57","author":"PA Noseworthy","year":"2011","unstructured":"Noseworthy PA, Tikkanen JT, Porthan K, Oikarinen L, Pietil\u00e4 A, Harald K et al (2011) The early repolarization pattern in the general population: clinical correlates and heritability. J Am Coll Cardiol 57:2284\u20132289. https:\/\/doi.org\/10.1016\/j.jacc.2011.01.040","journal-title":"J Am Coll Cardiol"},{"key":"4141_CR58","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","volume":"20","author":"P Brugada","year":"1992","unstructured":"Brugada P, Brugada J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 20:1391\u20131396. https:\/\/doi.org\/10.1016\/0735-1097(92)90253-J","journal-title":"J Am Coll Cardiol"},{"key":"4141_CR59","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fphys.2012.00360","volume":"3","author":"PC Yang","year":"2012","unstructured":"Yang PC, Clancy CE (2012) In silico prediction of sex-based differences in human susceptibility to cardiac ventricular tachyarrhythmias. Front Physiol 3:360. https:\/\/doi.org\/10.3389\/fphys.2012.00360","journal-title":"Front Physiol"},{"key":"4141_CR60","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1001\/jama.1993.03510210076031","volume":"270","author":"RR Makkar","year":"1993","unstructured":"Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH (1993) Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 270:2590\u20132597. https:\/\/doi.org\/10.1001\/jama.1993.03510210076031","journal-title":"JAMA"},{"key":"4141_CR61","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1161\/01.CIR.94.10.2535","volume":"94","author":"MH Lehmann","year":"1996","unstructured":"Lehmann MH, Hardy S, Archibald D, Quart B, MacNeil DJ (1996) Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation 94:2535\u20132541. https:\/\/doi.org\/10.1161\/01.CIR.94.10.2535","journal-title":"Circulation"},{"key":"4141_CR62","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2165\/00002018-200124080-00002","volume":"24","author":"MD Drici","year":"2001","unstructured":"Drici MD, Cl\u00e9ment N (2001) Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf 24:575\u2013585. https:\/\/doi.org\/10.2165\/00002018-200124080-00002","journal-title":"Drug Saf"},{"key":"4141_CR63","doi-asserted-by":"publisher","first-page":"e0155649","DOI":"10.1371\/journal.pone.0155649","volume":"11","author":"S Sch\u00e4chtele","year":"2016","unstructured":"Sch\u00e4chtele S, T\u00fcmena T, Ga\u00dfmann KG, Fromm MF, Maas R (2016) Co-prescription of QT interval-prolonging drugs: an analysis in a large cohort of geriatric patients. PLoS ONE 11:e0155649. https:\/\/doi.org\/10.1371\/journal.pone.0155649","journal-title":"PLoS ONE"},{"key":"4141_CR64","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5935\/abc.20150069","volume":"106","author":"D Garcia-Fuertes","year":"2016","unstructured":"Garcia-Fuertes D, Villanueva-Fernandez E, Crespin-Crespin M (2016) Drug-induced long-QT and torsades de pointes in elderly polymedicated patients. Arq Bras Cardiol 106:158\u2013160. https:\/\/doi.org\/10.5935\/abc.20150069","journal-title":"Arq Bras Cardiol"},{"key":"4141_CR65","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00264-017-3480-2","volume":"74","author":"CPM Heemskerk","year":"2018","unstructured":"Heemskerk CPM, Pereboom M, van Stralen K, Berger FA, van den Bemt PMLA, Kuijper AFM et al (2018) Risk factors for QTc interval prolongation. Eur J Clin Pharmacol 74:183\u2013191. https:\/\/doi.org\/10.1007\/s00264-017-3480-2","journal-title":"Eur J Clin Pharmacol"},{"key":"4141_CR66","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1517\/17425255.2012.680886","volume":"8","author":"R Rahimi","year":"2012","unstructured":"Rahimi R, Abdollahi M (2012) An update on the ability of St. John\u2019s wort to affect the metabolism of other drugs. Expert Opin Drug Metab Toxicol 8:691\u2013708. https:\/\/doi.org\/10.1517\/17425255.2012.680886","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4141_CR67","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","volume":"10","author":"SG Priori","year":"2013","unstructured":"Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C et al (2013) HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm 10:1932\u20131963. https:\/\/doi.org\/10.1016\/j.hrthm.2013.05.014","journal-title":"Heart Rhythm"},{"key":"4141_CR68","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/heartjnl-2020-318259","volume":"108","author":"AA Wilde","year":"2022","unstructured":"Wilde AA, Amin AS, Postema PG (2022) Diagnosis, management and therapeutic strategies for congenital long QT syndrome. Heart 108:332\u2013338. https:\/\/doi.org\/10.1136\/heartjnl-2020-318259","journal-title":"Heart"},{"key":"4141_CR69","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/CIRCEP.113.000635","volume":"6","author":"JM Bos","year":"2013","unstructured":"Bos JM, Bos KM, Johnson JN, Moir C, Ackerman MJ (2013) Use of a combination ECG-genetic risk score improves long QT syndrome diagnosis compared with clinical methods alone. Circ Arrhythm Electrophysiol 6:951\u2013959. https:\/\/doi.org\/10.1161\/CIRCEP.113.000635","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"4141_CR70","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12872-025-04593-z","volume":"25","author":"M Mobasheri-Shiri","year":"2025","unstructured":"Mobasheri-Shiri M, Bazmi S, Soleimani-Meigoli MS, Karimimoghadam Z, Tabrizi R, Farjam M (2025) The association between insulin resistance and QT interval: a systematic review and meta-analysis. BMC Cardiovasc Disord 25:139. https:\/\/doi.org\/10.1186\/s12872-025-04593-z","journal-title":"BMC Cardiovasc Disord"},{"key":"4141_CR71","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/clc.24015","volume":"46","author":"A Naderi","year":"2023","unstructured":"Naderi A, Farjam M, Mojarrad Sani M, Abdollahi A, Alkamel A, Keshavarzian O et al (2023) The association between nonalcoholic fatty liver disease and corrected QT interval prolongation among generally healthy Iranian population: Fasa Cohort Study (FACS). Clin Cardiol 46:615\u2013621. https:\/\/doi.org\/10.1002\/clc.24015","journal-title":"Clin Cardiol"},{"key":"4141_CR72","doi-asserted-by":"publisher","first-page":"100525","DOI":"10.1016\/j.advnut.2025.100525","volume":"16","author":"A Mazzanti","year":"2025","unstructured":"Mazzanti A, Floriano M, Kukavica D, Trancuccio A, Priori SG (2025) Nutritional factors and arrhythmic risk in long QT syndrome: a narrative review of mechanistic and clinical evidence. Adv Nutr 16:100525. https:\/\/doi.org\/10.1016\/j.advnut.2025.100525","journal-title":"Adv Nutr"},{"key":"4141_CR73","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/CIRCOUTCOMES.113.000651","volume":"7","author":"JE Tisdale","year":"2014","unstructured":"Tisdale JE, Jaynes HA, Kingery JR, Overholser BR, Mourad NA, Trujillo TN et al (2014) Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes 7:381\u2013390. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.113.000651","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"4141_CR74","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1111\/bcp.13740","volume":"84","author":"E Vandael","year":"2018","unstructured":"Vandael E, Vandenberk B, Vandenberghe J, Van den Bosch B, Willems R, Foulon V (2018) A smart algorithm for the prevention and risk management of QTc prolongation based on the optimized RISQ-PATH model. Br J Clin Pharmacol 84:2824\u20132835. https:\/\/doi.org\/10.1111\/bcp.13740","journal-title":"Br J Clin Pharmacol"},{"key":"4141_CR75","doi-asserted-by":"publisher","unstructured":"Woosley RL, Heise CW, Romero K (2020) QTDrugs List: AZCERT, Inc. CredibleMeds\/QTDrugs [Internet]. https:\/\/doi.org\/10.1002\/cpt.2013","DOI":"10.1002\/cpt.2013"},{"key":"4141_CR76","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ddtec.2018.06.003","volume":"27","author":"RL Woosley","year":"2018","unstructured":"Woosley RL, Romero K (2018) QT liability: the potential for drug-induced sudden cardiac death in the drug development process. Drug Discov Today Technol 27:45\u201352. https:\/\/doi.org\/10.1016\/j.ddtec.2018.06.003","journal-title":"Drug Discov Today Technol"},{"key":"4141_CR77","doi-asserted-by":"publisher","first-page":"ooab023","DOI":"10.1093\/jamiaopen\/ooab023","volume":"4","author":"E Chou","year":"2021","unstructured":"Chou E, Boyce RD, Balkan B, Subbian V, Romero A, Hansten PD et al (2021) Designing and evaluating contextualized drug-drug interaction algorithms. JAMIA Open 4:ooab023. https:\/\/doi.org\/10.1093\/jamiaopen\/ooab023","journal-title":"JAMIA Open"},{"key":"4141_CR78","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0735-1097(00)00927-6","volume":"36","author":"S Viskin","year":"2000","unstructured":"Viskin S, Fish R, Zeltser D, Belhassen B, Heller K, Brosh D et al (2000) Arrhythmias in the congenital long QT syndrome: how often is it torsade de pointes? J Am Coll Cardiol 36:1827\u20131833. https:\/\/doi.org\/10.1016\/S0735-1097(00)00927-6","journal-title":"J Am Coll Cardiol"},{"key":"4141_CR79","doi-asserted-by":"publisher","first-page":"107850","DOI":"10.1016\/j.jaccas.2026.107850","volume":"31","author":"VC Mystakidi","year":"2026","unstructured":"Mystakidi VC, Pantelidis P, Gerostathis A, Dilaveris PE, Siasos G (2026) From complete heart block to torsades de pointes: an axis to remember. JACC Case Rep 31:107850. https:\/\/doi.org\/10.1016\/j.jaccas.2026.107850","journal-title":"JACC Case Rep"},{"key":"4141_CR80","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/europace\/eur393","volume":"14","author":"AL Aro","year":"2012","unstructured":"Aro AL, Huikuri HV, Tikkanen JT, Junttila MJ, Rissanen HA, Reunanen A et al (2012) QRS-T angle as a predictor of sudden cardiac death in a middle-aged general population. Europace 14:872\u2013876. https:\/\/doi.org\/10.1093\/europace\/eur393","journal-title":"Europace"},{"key":"4141_CR81","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1161\/01.CIR.0000034670.06526.15","volume":"106","author":"RJ Gibbons","year":"2002","unstructured":"Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF et al (2002) ACC\/AHA 2002 guideline update for exercise testing: summary article. Circulation 106:1883\u20131892. https:\/\/doi.org\/10.1161\/01.CIR.0000034670.06526.15","journal-title":"Circulation"},{"key":"4141_CR82","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jamacardiol.2023.3017","volume":"8","author":"RB Patel","year":"2023","unstructured":"Patel RB, Ng J, Bhairavia V, Scheinman MM, Goldberger JJ (2023) ECG-based risk stratification of sudden cardiac death. JAMA Cardiol 8:967\u2013975. https:\/\/doi.org\/10.1001\/jamacardiol.2023.3017","journal-title":"JAMA Cardiol"},{"key":"4141_CR83","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jacc.2011.06.029","volume":"58","author":"RL Verrier","year":"2011","unstructured":"Verrier RL, Klingenheben T, Malik M, El-Sherif N, Exner DV, Hohnloser SH et al (2011) Microvolt T-wave alternans: physiological basis, methods of measurement, and clinical utility\u2014consensus guideline by the International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol 58:1309\u20131324. https:\/\/doi.org\/10.1016\/j.jacc.2011.06.029","journal-title":"J Am Coll Cardiol"},{"key":"4141_CR84","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.111.080887","volume":"125","author":"AJ Sauer","year":"2012","unstructured":"Sauer AJ, Newton-Cheh C (2012) Clinical and genetic determinants of torsade de pointes risk. Circulation 125:1684\u20131694. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.080887","journal-title":"Circulation"},{"key":"4141_CR85","doi-asserted-by":"publisher","first-page":"177","DOI":"10.15420\/aer.2016.26.2","volume":"5","author":"DG Katritsis","year":"2016","unstructured":"Katritsis DG, Gersh BJ, Camm AJ (2016) A clinical perspective on sudden cardiac death. Arrhythm Electrophysiol Rev 5:177\u2013182. https:\/\/doi.org\/10.15420\/aer.2016.26.2","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"4141_CR86","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1161\/01.CIR.0000145144.56673.59","volume":"110","author":"BJ Drew","year":"2004","unstructured":"Drew BJ, Califf RM, Funk M, Kaufman ES, Krucoff MW, Laks MM et al (2004) Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement. Circulation 110:2721\u20132746. https:\/\/doi.org\/10.1161\/01.CIR.0000145144.56673.59","journal-title":"Circulation"},{"key":"4141_CR87","doi-asserted-by":"publisher","first-page":"1748382","DOI":"10.3389\/fcvm.2026.1748382","volume":"13","author":"PY Kim","year":"2026","unstructured":"Kim PY, Ostos Mendoza KC, Kim JH et al (2026) QT monitoring in chemotherapy. Front Cardiovasc Med 13:1748382. https:\/\/doi.org\/10.3389\/fcvm.2026.1748382","journal-title":"Front Cardiovasc Med"},{"key":"4141_CR88","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/europace\/eut214","volume":"16","author":"G Sarganas","year":"2014","unstructured":"Sarganas G, Garbe E, Klimpel A, Hering RC, Bronder E, Haverkamp W (2014) Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany. Europace 16:101\u2013108. https:\/\/doi.org\/10.1093\/europace\/eut214","journal-title":"Europace"},{"key":"4141_CR89","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","volume":"103","author":"SG Priori","year":"2001","unstructured":"Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R et al (2001) Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103:196\u2013200. https:\/\/doi.org\/10.1161\/01.CIR.103.2.196","journal-title":"Circulation"},{"key":"4141_CR90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s43856-024-00451-9","volume":"4","author":"L Holmstrom","year":"2024","unstructured":"Holmstrom L, Chugh H, Nakamura K, Bhanji Z, Seifer M, Uy-Evanado A et al (2024) An ECG-based artificial intelligence model for assessment of sudden cardiac death risk. Commun Med (Lond) 4:17. https:\/\/doi.org\/10.1038\/s43856-024-00451-9","journal-title":"Commun Med (Lond)"},{"key":"4141_CR91","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/eurheartj\/ehab588","volume":"42","author":"E Prifti","year":"2021","unstructured":"Prifti E, Fall A, Davogustto G, Pulini A, Denjoy I, Funck-Brentano C et al (2021) Deep learning analysis of electrocardiogram for risk prediction of drug-induced arrhythmias and diagnosis of long QT syndrome. Eur Heart J 42:3948\u20133961. https:\/\/doi.org\/10.1093\/eurheartj\/ehab588","journal-title":"Eur Heart J"},{"key":"4141_CR92","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.hrthm.2025.10.045","volume":"23","author":"L Jing","year":"2026","unstructured":"Jing L, Morland TB, Kelsey CR, Raghunath S, Pfeifer JM, Ruhl JA et al (2026) Machine learning-enabled assessment of risk of drug-induced QT prolongation at the time of prescribing. Heart Rhythm 23:925\u2013935. https:\/\/doi.org\/10.1016\/j.hrthm.2025.10.045","journal-title":"Heart Rhythm"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04141-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04141-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04141-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:47:31Z","timestamp":1789454851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04141-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":92,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4141"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04141-4","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"6 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was not necessary because no patient data has been included in the manuscript.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"239"}}